Conditions: Thyroid Neoplasms
Keywords: VEGFR inhibitor tyrosine kinase inhibitor anti-angiogenic carcinoma papillary follicular medullary anaplastic
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 52
Healthy volunteers: no

Brief summary:
The primary purpose is to determine how effective AG-013736 is in shrinking thyroid cancer that is resistant to radioactive iodine

Detailed description:
Additional study details: assess safety and efficacy

Arms:
arm 1: None

Interventions: intervention 1: AG-013736
Intervention descriptions: intervention 1: AG-013736, tablets 5 mg BID , treatment will continue until tumor progression or toxicity

Protocol document: